Assignee
SK BIOSCIENCE CO LTD
KR·9 granted patents·18 pending applications·3 citations·filing 2018–2025
Top patents by PatentIndex Score
27 records- 0191US12440548B2Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereofSK BIOSCIENCE CO LTD·Filed 2024·Granted Oct 14, 2025·1 cites·8 claims
- 0282US2026007732A1Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereofSK BIOSCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 0379US11883483B2Method for preparing influenza working virus seed stock, method for preparing influenza vaccine using same seed stock, and virus seed stock prepared by same methodSK BIOSCIENCE CO LTD·Filed 2018·Granted Jan 30, 2024·2 cites·12 claims
- 0469US11951162B2Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereofSK BIOSCIENCE CO LTD·Filed 2019·Granted Apr 9, 2024·0 cites·16 claims
- 0563US2025354157A1Mrna for protein expression and template thereforSK BIOSCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 0663US2024344019A1Method for stably maintaining poly(a) tailSK BIOSCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 0762US12304929B2Recombinant RSV live vaccine strain and the preparing method thereofSK BIOSCIENCE CO LTD·Filed 2022·Granted May 20, 2025·0 cites·14 claims
- 0862US2026014247A1Sars-cov-2 vaccine booster compositionSK BIOSCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 0960US2025295750A1Chimeric zika virus anticancer vaccine obtained through breast cancer cell passageSK BIOSCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 1059US2025346867A1Method for preparing reassortant rotavirusSK BIOSCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 1158US2024309336A1Method for producing reassortant reoviridae virus, and vector library for sameSK BIOSCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 1258US2025134971A1Mrna for protein expression and template thereforSK BIOSCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 1357US12558417B2Hepatitis A virus preparation method and hepatitis A virus prepared according to methodSK BIOSCIENCE CO LTD·Filed 2020·Granted Feb 24, 2026·0 cites·22 claims
- 1456US12076393B2Vaccine composition for prevention or treatment of SARS-coronavirus-2 infectionSK BIOSCIENCE CO LTD·Filed 2021·Granted Sep 3, 2024·0 cites·15 claims
- 1556US2025127872A1Recombinant live attenuated rsv vaccine strain and production method thereforSK BIOSCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 1655US12454680B2Vero cell line that can be suspension-cultured in serum-free medium, preparation method therefor, and method for preparing viruses for vaccines by using novel cell lineSK BIOSCIENCE CO LTD·Filed 2020·Granted Oct 28, 2025·0 cites·9 claims
- 1755US2024059730A1High-yield purification method for target proteinSK BIOSCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 1855US2025276028A1Composition for reducing size or volume of target tissue or kit including sameSK BIOSCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 1952US2025139473A1Method And Apparatus For Designing ExperimentSK BIOSCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 2052US2025054129A1Vial inspection apparatus and method based on hyperspectral image and ai modelSK BIOSCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 2150US12252529B2Streptococcus pneumoniae antiserum without cross-reactivity and method for producing the sameSK BIOSCIENCE CO LTD·Filed 2020·Granted Mar 18, 2025·0 cites·12 claims
- 2249US2023212230A1Influenza virus production method using single-use culture process system and rapid confirmation test of influenza virus antigen purification conditionSK BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 2348US12344636B2Respiratory syncytial virus recombinant F protein and vaccine composition containing sameSK BIOSCIENCE CO LTD·Filed 2019·Granted Jul 1, 2025·0 cites·16 claims
- 2448US2025332250A1Vaccine composition or kit for reducing size or volume of target tissue, containing genetic material that encodes foreign antigenSK BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 2547US2025281594A1Truncated recombinant l1 protein of human papillomavirusSK BIOSCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 2646US2023257425A1Vaccine composition for preventing or treating infection of sars-cov-2SK BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 2743US2021355169A1Recombinant rsv live vaccine strain and production method thereforSK BIOSCIENCE CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SK BIOSCIENCE CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →